Tag Archive for: real-world evidence

As clinical stage biotech and pharmaceutical firms face unprecedented challenges in raising capital to fund their clinical trial program, strategic trade-offs are coming fast and furious. One of those at the top of the list is when and how to build a commercialization strategy, including navigating the complex work of securing market access.

Even with the COVID-19 emergency measures, payers still had an eye on the potential flood of gene therapies for rare diseases brewing in the pipeline, and were pondering new ways to pay for them. 

Med Ad News caught up with Fishawack Health CEO Jon Koch and Avalere Health President Elizabeth Carpenter to discuss the deal and why it took place, and what Avalere brings to Fishawack.